Shilpa Medicare shares zoomed over 4% after the company announced that it has received an Establishment Inspection Report (EIR) for the Bengaluru unit from the USFDA. At around 2.06 PM, Shilpa ...

Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health ...

Karnataka: Shilpa Medicare Limited has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI ...

Shilpa Medicare added 2.94% to Rs 920.70 after the company announced that its Unit VI facility in Dabaspet, Bengaluru, Karnataka, has received EIR with VAI (Voluntary Action Indicated) classification ...

The company, in an exchange filing on July 16, said that Unit VI, Dabaspet, Bengaluru, Karnataka, India, has received an EIR with VAI (Voluntary Action Indicated) classification from the US FDA.

Shilpa Medicare's facility in Bengaluru is capable of manufacturing, packaging, testing, storage and distribution of two ...

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received ...

The inspection, conducted by Brazilian regulatory authority ANVISA, was held between June 30 and July 4. Earlier, it had ...

Review Shilpa Medicare Ltd (530549:XBOM) stock and the current sustainability and ESG risk rating to help with your investing decisions.

View the latest Shilpa Medicare Ltd. (SHILPAMED) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Shilpa Medicare Ltd (BOM:530549) reports robust revenue growth and strategic progress, despite facing regulatory and market challenges.

Shilpa Medicare launched a new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will serve both small and large molecule customers as well as peptides – with oncology as a therapeutic ...